Psoriatic arthritis diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The [[diagnosis]] of psoriatic arthritis is easily confirmed when the [[Skin|cutaneous]] manifestations of [[psoriasis]] coexist with [[arthritis]]. There is no definitive [[diagnostic test]] for psoriatic arthritis. It must be differentiated from other arthritides based on the [[joint]] involvement patterns, clinical features, [[imaging]] and [[Medical laboratory|laboratory]] studies. The CASPAR criteria (ClASsification criteria for Psoriatic ARthritis) has been propsed to diagnose psoriatic arthritis using point scoring system.
== Diagnostic Study of Choice ==
== Diagnostic Study of Choice ==
* There is no definitive [[diagnostic test]] for psoriatic arthritis.
* [[Radiography]], [[Magnetic resonance imaging|MRI]] and [[Computed tomography|CT scan]] may be helpful in diagnosing psoriatic arthritis from other arthritides.


==Diagnostic Criteria==
==Diagnostic Criteria==

Revision as of 20:10, 15 May 2018

Psoriatic arthritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Psoriatic arthritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary prevention

Secondary prevention

Future or Investigational Therapies

Case Studies

Case #1

Psoriatic arthritis diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Psoriatic arthritis diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Psoriatic arthritis diagnostic study of choice

CDC on Psoriatic arthritis diagnostic study of choice

Psoriatic arthritis diagnostic study of choice in the news

Blogs onPsoriatic arthritis diagnostic study of choice

Directions to Hospitals Treating Rheumatoid arthritis

Risk calculators and risk factors for Psoriatic arthritis diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

The diagnosis of psoriatic arthritis is easily confirmed when the cutaneous manifestations of psoriasis coexist with arthritis. There is no definitive diagnostic test for psoriatic arthritis. It must be differentiated from other arthritides based on the joint involvement patterns, clinical features, imaging and laboratory studies. The CASPAR criteria (ClASsification criteria for Psoriatic ARthritis) has been propsed to diagnose psoriatic arthritis using point scoring system.

Diagnostic Study of Choice

Diagnostic Criteria

  • The diagnosis of psoriatic arthritis is easily confirmed when the cutaneous manifestations of psoriasis coexist with arthritis.[1][2][3][4]
  • It must be differentiated from other arthritides based on the joint involvement patterns, clinical features, imaging and laboratory studies.
  • The following manifestations may be helpful in diagnosing psoriatic arthritis in an individual in the absence of psoriatic skin lesions.[5]
Family history of psoriasis in first degree relatives
Asymmetric joint distribution
Involvement of distal joints
Nail involvement (eg, pitting, nail bed destruction, onycholysis)
Dactylitis
Hidden psoriatic plaques
  • The CASPAR criteria (ClASsification criteria for Psoriatic ARthritis):[6]
    • The CASPAR study stated that a patient present with inflammatory articular disease (inflammatory peripheral arthritis, enthesitis, spondylitis) can be diagnosed as having psoriatic arthritis if a total of at least three points are present from the presence of the following possibilities.
Manifestation Point score
Skin lesions Current psoriasis: 2 points

Previous history of psoriasis: 1 point

The family history of psoriasis: 1 point

Dactylitis 1 point
Nail dystrophy 1 point
Juxtra articular new bone formation 1 point
Abscence of rheumatoid factor 1 point
  • The specificity is approximately 98.7% and sensitivity is approximately 91.4%.

References

  1. Liu JT, Yeh HM, Liu SY, Chen KT (September 2014). "Psoriatic arthritis: Epidemiology, diagnosis, and treatment". World J Orthop. 5 (4): 537–43. doi:10.5312/wjo.v5.i4.537. PMC 4133459. PMID 25232529.
  2. WRIGHT V (December 1956). "Psoriasis and arthritis". Ann. Rheum. Dis. 15 (4): 348–56. PMC 1006908. PMID 13395269.
  3. Helliwell PS, Taylor WJ (March 2005). "Classification and diagnostic criteria for psoriatic arthritis". Ann. Rheum. Dis. 64 Suppl 2: ii3–8. doi:10.1136/ard.2004.032318. PMC 1766878. PMID 15708931.
  4. Punzi L, Pianon M, Rossini P, Schiavon F, Gambari PF (April 1999). "Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease". Ann. Rheum. Dis. 58 (4): 226–9. PMC 1752862. PMID 10364901.
  5. Scarpa R, Cosentini E, Manguso F, Oriente A, Peluso R, Atteno M, Ayala F, D'Arienzo A, Oriente P (December 2003). "Clinical and genetic aspects of psoriatic arthritis "sine psoriasis"". J. Rheumatol. 30 (12): 2638–40. PMID 14719207.
  6. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (August 2006). "Classification criteria for psoriatic arthritis: development of new criteria from a large international study". Arthritis Rheum. 54 (8): 2665–73. doi:10.1002/art.21972. PMID 16871531.

Template:WH Template:WS